Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HTR2A | P28223 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.53 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19645377 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL8705439 | 0.91 | KDM4E (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL3310267 | 0.91 | CYP1A2 (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL15564459 | 0.89 | CYP1A2 (0.49) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL1430742 | 0.89 | IDO1 (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL477415 | 0.89 | IDO1 (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL477416 | 0.89 | IDO1 (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL16995185 | 0.89 | IDO1 (0.53) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL4676513 | 0.85 | CYP1A2 (0.49) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 | |
| SCHEMBL17840999 | 0.85 | KDM4E (0.49) | CYP1A2CYP2D6KDM4EHTR2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| WO-2004111092-A1 | MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-12-23 | — | — | WO | claimed |
| US-20040253532-A1 | Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof | MERCK PATENT GMBH (DE) | 2004-12-16 | — | — | US | claimed |
| JP-62205038-A | — | — | None | — | — | JP | disclosed |
| US-20260000642-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | TAY THERAPEUTICS LTD (GB) | 2026-01-01 | — | — | US | disclosed |
| US-20250263370-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | Tay Therapeutics Limited (GB) | 2025-08-21 | — | — | US | disclosed |
| EP-4558224-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | Tay Therapeutics Limited (GB) | 2025-05-28 | — | — | EP | disclosed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | disclosed |
| CN-118812335-A | Method for preparing aldehyde or ketone by alcohol oxidation | 浙江工业大学 | 2024-10-22 | — | — | CN | disclosed |
| US-20240293381-A1 | Therapeutic Compounds | CELGENE QUANTICEL RES INC (US) | 2024-09-05 | — | — | US | disclosed |
| EP-0254195-A2 | Photographic silver halide developer compositions and process for forming photographic silver images | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-01-27 | — | — | EP | disclosed |
| US-4693956-A | USING A HYDRAZINE, ANTIFOGGING AGENT AND A HYDROXYMETHYLIDYNE-CONTAINING COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-09-15 | — | — | US | disclosed |
| JP-S62205038-A | PRODUCTION OF 4-FLUORO-1-BUTENE DERIVATIVE | RIKAGAKU KENKYUSHO | 1987-09-09 | — | — | JP | disclosed |
| EP-0182293-A2 | Process for high contrast development of photographic elements | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1986-05-28 | — | — | EP | disclosed |
| US-4529810-A | Preparation of optically-active alpha-substituted carboxylic esters and acids | SHELL OIL COMPANY (US) | 1985-07-16 | — | — | US | disclosed |
| EP-0041362-A1 | 1-Olefin polymerization process and catalyst | HERCULES INCORPORATED (US) | 1981-12-09 | — | — | EP | disclosed |
| US-4022903-A | α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides | ABBOTT LABORATORIES (US) | 1977-05-10 | — | — | US | disclosed |
| US-4022903-A | α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides | ABBOTT LABORATORIES (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293381-A1 | Therapeutic Compounds | EP300, BRD4, BRD3 | CYP1A2 4769/4885CYP2D6 4794/4885KDM4E 93/4885 |
| US-20260000642-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | BET1, BRD4, PHKB | CYP1A2 3117/4885CYP2D6 3645/4885KDM4E 947/4885 |
| US-20250263370-A1 | PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS | BET1, PHKB, BRD4 | CYP1A2 4517/4885CYP2D6 4476/4885KDM4E 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.